Kyowa Kirin
Headquarters in Otemachi, Chiyoda, Tokyo | |
| Formerly | Kyowa Hakko Kogyo Co., Ltd. (1949–2008) |
|---|---|
| Company type | Public |
| TYO: 4151 Nikkei 225 Component | |
| Industry | |
| Predecessor | Kirin Pharma |
| Founded | July 1, 1949 |
| Headquarters | Ohtemachi Building, 1-6-1, Ōtemachi, Chiyoda-ku, Tokyo 100–8185, Japan |
Key people | Nobuo Hanai, (CEO and president) |
| Products | |
| Revenue | $ 2.99 billion USD (FY 2022) (¥ 398.4 billion JPY) (FY 2022) |
| $ 375 million USD (FY 2022) (¥ 53.6 billion JPY) (FY 2022) | |
Number of employees | 7,532 (consolidated) (as of December 31, 2017) |
| Parent | Kirin Holdings Company, Limited |
| Subsidiaries | 47 (33 in Japan and 14 overseas countries) |
| Website | Official website |
| Footnotes / references | |
Kyowa Kirin Co., Ltd. (協和キリン株式会社, Kyōwa Kirin Kabushiki Kaisha) is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index.